Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or
cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic
control, intensive blood pressure control, and multiple lipid management.
Phase:
Phase 3
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators:
Centers for Disease Control and Prevention National Eye Institute (NEI) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Aging (NIA)